AQR Capital Management
MESO

AQR Capital Management’s Mesoblast MESO Stock Holding History

AQR Capital Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$390K Buy
25,344
+129
+0.5% +$2.15K ﹤0.01% 3268
2025
Q4 		$455K Buy
25,215
+11,242
+80% +$193K ﹤0.01% 2967
2025
Q3 		$225K Buy
13,973
+41
+0.3% +$600 ﹤0.01% 3208
2025
Q2 		$152K Buy
+13,932
New +$156K ﹤0.01% 3113

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AQR Capital Management's MESO Position: Q1 2026 in Review

AQR Capital Management increased its Mesoblast (MESO) stake by 0.51% in Q1 2026, buying an estimated $2.15K and bringing the position to 25,344 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #3268.

AQR Capital Management first reported a position in MESO in Q2 2025 and has held it in 4 quarters since. The position peaked at $455K in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • AQR Capital Management held 25,344 shares of Mesoblast worth $390K as of Q1 2026.
  • AQR Capital Management bought 129 Mesoblast shares in Q1 2026, an estimated $2.15K.
  • Mesoblast made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3268 holding.
  • AQR Capital Management first reported a position in Mesoblast in Q2 2025 and has held it in 4 quarters since.
  • AQR Capital Management's Mesoblast position peaked at $455K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.